To get a peptide prescribed, start with a licensed clinician who can review your health history, goals, current medicines, and relevant risks. The right path depends on the specific treatment and intended use. At Chia, patients complete an online questionnaire, and a licensed US provider decides whether treatment is clinically appropriate; a prescription is never guaranteed.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What does getting a peptide prescription involve?
Getting a prescription involves more than selecting a product online. A clinician needs enough information to decide whether a medication may be appropriate, whether there are safety concerns, and what follow-up is needed. A prescription requires an individual medical evaluation, whether that happens in person or through telehealth.8
Why the specific peptide and intended use matter
“Peptide” describes a broad group of compounds, not one treatment category. Some peptide-based medicines have FDA-approved uses backed by large human trials. Others have limited human data, are studied only in animals or cells, or are sold online without an approved medical use. That difference matters when a clinician weighs likely benefit, side effects, interactions, and alternatives.3 4
What a licensed provider reviews before prescribing
- Your health history, including conditions that could change the safety of treatment.
- Current prescription medicines, over-the-counter products, and supplements that may affect treatment decisions.
- Your treatment goal and whether the medication has evidence for that goal in people like you.
- Potential side effects, contraindications, follow-up needs, and whether another approach is more appropriate.1 2
Do you need a prescription for peptides?
For prescription peptide medications, yes: a licensed prescriber must make the prescription decision. A website can collect your information, but it cannot replace the clinical assessment required to determine whether a prescription is appropriate.8
Prescription medications versus research chemicals
Some online sellers market injectable peptides as “research use only” or “not for human consumption.” Those labels do not make a product appropriate for self-treatment. FDA warns that unapproved products may have quality, dosing, labeling, and contamination concerns, and an online listing does not establish that a product was made under standards appropriate for patient care.4
Why no-prescription injections are a warning sign
A seller that promises injectable medication without a prescription removes the clinician from the part of care that identifies contraindications, reviews medicines, and plans follow-up. For a practical overview of safer access, read our guide to where to get peptide injections safely.
Which peptides can a clinician prescribe?
Clinicians can prescribe medications that are legally available within their scope of practice, but the evidence and regulatory status differ by product. Semaglutide and tirzepatide have the strongest human weight-management trial evidence among the treatments discussed here, while many other peptides require much more caution when interpreting claims.1 2
GLP-1-based treatment: semaglutide and tirzepatide
Wegovy and Ozempic are brand names for semaglutide, a GLP-1 receptor agonist. Zepbound and Mounjaro are brand names for tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. FDA-approved branded products have distinct labeled indications; clinicians should not treat brand-label evidence as proof of outcomes for a compounded formulation.1 2
In the STEP 1 trial, semaglutide 2.4 mg once weekly was studied in adults with overweight or obesity without diabetes alongside lifestyle intervention; gastrointestinal side effects were common. In SURMOUNT-1, tirzepatide was studied in adults with obesity or overweight without diabetes, and gastrointestinal adverse events were also common. Individual results vary, and these trials do not establish results for compounded formulations.5 6
Other peptide treatments and evidence limits
Other peptide treatments may be used for different clinical goals, but one peptide’s research cannot be transferred to another. Potential uses, safety considerations, and evidence are not interchangeable with GLP-1 treatment. Our overview of GLP-1 peptides explains the GLP-1 class in more detail.
What it means when a medication is compounded
A compounded medication is prepared by a compounding pharmacy for an individual patient pursuant to a prescription. FDA does not approve compounded drugs, and it does not review them before marketing for safety, effectiveness, or quality in the way it reviews FDA-approved drugs.3 Compounding status and availability can also change, so a licensed provider and pharmacy are important parts of the access process.
3-min quiz
Explore clinician-reviewed treatment options
Chia offers compounded semaglutide and compounded tirzepatide after a licensed-provider evaluation. A prescription requires a medical review and is not guaranteed. Medications are compounded by US state-licensed 503A pharmacies; compounded drugs are not FDA-approved.
How can you get semaglutide or tirzepatide prescribed online?
A legitimate online path includes a health intake, licensed-provider review, a prescription only when clinically appropriate, and pharmacy fulfillment. Online care can be convenient, but it does not bypass eligibility or safety review. Professional guidance on telemedicine emphasizes that clinicians must meet applicable standards of care and evaluate whether telehealth is suitable for the patient.8
Semaglutide online
Semaglutide has been studied in people with type 2 diabetes and in people with overweight or obesity in different trials and formulations. Side effects in studies commonly included gastrointestinal symptoms, and clinical decisions should account for an individual’s medical history and medications.5 7 Chia currently offers compounded semaglutide as an injection, with provider-guided microdosing plans available for eligible patients. Compounded drugs are not FDA-approved.3
Tirzepatide online
Tirzepatide has also been studied in type 2 diabetes and weight-management populations. In SURMOUNT-1, the most frequent adverse events were gastrointestinal and were generally mild to moderate, although treatment decisions still require individualized risk review.6 Chia currently offers compounded tirzepatide as tablets or injection, with provider-guided microdosing plans available for eligible patients. Compounded drugs are not FDA-approved.3
What happens during an online peptide evaluation?
An online evaluation should gather the information a clinician needs to make a responsible decision, not simply process a purchase. The process begins with a health questionnaire and clinical review, and a provider may need follow-up information before deciding next steps.8
- 1Complete a health questionnaire about your health history, goals, current medicines, and relevant risks.
- 2A licensed provider reviews the information and may ask follow-up questions.
- 3If treatment is clinically appropriate, the provider may issue a prescription; if not, they may recommend a different next step.
- 4When prescribed through Chia, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to the patient’s door. Compounded drugs are not FDA-approved.3
- 5Patients can message their care team through the patient portal between visits, and dosing is provider-guided over time.
How does peptide treatment at Chia work?
At Chia, treatment starts with an online health questionnaire and review by a licensed US provider. Chia is fully online, but prescriptions are never automatic: a provider prescribes only when they determine treatment is clinically appropriate.
Our current catalog includes compounded semaglutide injections and compounded tirzepatide tablets or injections for eligible patients. We also offer selected treatments in other categories, including Sermorelin, NAD+, glutathione, GHK-Cu, PT-141, estradiol, and progesterone. Availability, form, and clinical appropriateness differ by treatment. Compounded drugs are not FDA-approved.3
| Chia treatment | Forms currently available | Current starting price where listed |
|---|---|---|
| Semaglutide | Injection; microdosing plans available | From $249/mo |
| Tirzepatide | Tablets or injection; microdosing plans available | Tablets from $249/mo; injection from $299/mo |
| Sermorelin | Injection, nasal spray, tablets | Injection or nasal spray from $179/mo |
| NAD+ | Injection or nasal spray | Injection from $179/mo; nasal spray from $119/mo |
| Glutathione | Injection or nasal spray | From $179/mo |
| GHK-Cu | Cream | From $159/mo |
| PT-141 | Nasal spray | From $159/mo |
| Estradiol | Cream, tablets, transdermal patch, injection | Tablets from $109/mo |
| Progesterone | Cream or tablets | Tablets from $109/mo |
For semaglutide, Chia currently offers injections. For tirzepatide, patients and providers can discuss tablets or injections where treatment is appropriate. Our providers guide dosing and adjustments over time, including microdosing plans for eligible semaglutide and tirzepatide patients. Compounded drugs are not FDA-approved.3 Plans currently start at the prices shown above; see the semaglutide page or tirzepatide page for current details.
How should you compare online peptide providers?
Compare the care process, not just the advertised product or price. A legitimate provider should clearly identify clinician involvement and pharmacy sourcing before you share health information or pay for treatment.3 8
| What to compare | Clinician-reviewed telehealth care | Unverified online seller |
|---|---|---|
| Prescription decision | Licensed clinician evaluates whether treatment is appropriate | May claim no prescription is needed |
| Health review | Reviews history, medicines, and risks | Often limited or absent |
| Medication source | Discloses pharmacy sourcing and prescription process | May use vague “research” or “lab” language |
| Follow-up | Offers a path for questions and ongoing care | May provide product sales only |
| Promises | Does not guarantee a prescription or outcome | May promise approval, rapid results, or universal eligibility |
- Ask who will review your information and whether that person is licensed to prescribe in your state.
- Ask which pharmacy will fill the prescription and whether it is state-licensed.
- Read how follow-up, side-effect questions, and dose changes are handled.
- Be cautious about guaranteed prescriptions, no-prescription injections, or claims that every peptide has the same benefits. FDA has described risks associated with unapproved GLP-1 products and misleading online marketing.4
What are the safety and evidence limits to understand first?
The main safety question is not simply whether something is called a peptide. Evidence, risks, and regulatory status vary substantially by compound and intended use. A clinician can help separate established evidence from marketing claims and assess whether treatment is reasonable for you.1 2
For weight management, biological changes after weight loss can persist, which is one reason lasting care should not be framed as a simple product purchase. In a clinical study of weight loss, researchers found persistent hormonal adaptations associated with appetite regulation one year later.7 That finding does not determine any one person’s outcome, but it supports taking a long-term, clinician-guided view.
Frequently asked questions about getting peptides prescribed
Yes, a telehealth provider may prescribe when permitted by applicable law and when they determine treatment is clinically appropriate after an individual evaluation. The exact process depends on the medication, your health information, and your state.
Prescription peptide injections should be obtained through a licensed clinician and pharmacy. Products sold without a prescription or as research chemicals are not a substitute for clinician-supervised treatment.
Yes, online providers can evaluate patients for semaglutide or tirzepatide. A licensed clinician must decide whether treatment is appropriate, and an online questionnaire does not guarantee a prescription.
No. The questionnaire begins the clinical review process. A provider may need more information, may determine a treatment is not appropriate, or may recommend a different next step.
No. Compounded medications are not FDA-approved, and FDA does not review compounded formulations before marketing in the same way it reviews FDA-approved drugs.
Chia currently offers compounded semaglutide injections and compounded tirzepatide tablets or injections after licensed-provider review. Provider-guided microdosing plans are available for eligible patients. Compounded drugs are not FDA-approved.
Look for a real licensed-provider evaluation, clear prescription requirements, transparent pharmacy sourcing, and a way to receive follow-up care. Be cautious of guaranteed prescriptions and no-prescription injectable offers.
3-min quiz
Start with a clinician-reviewed evaluation
If you are exploring semaglutide, tirzepatide, or another treatment Chia offers, begin with our online health questionnaire. A licensed US provider reviews each case, and a prescription is not guaranteed. Chia medications are compounded by state-licensed US 503A pharmacies and shipped to your door; compounded drugs are not FDA-approved.
References
- 1.U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. 2025.
- 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. 2025.
- 3.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2025.
- 4.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2025.
- 5.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 6.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- 7.Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine. 2011.
- 8.Federation of State Medical Boards. The Appropriate Use of Telemedicine Technologies in the Practice of Medicine. 2022.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.


